Septerna, Common Financials
| SEPN Stock | 24.76 0.53 2.10% |
Septerna, |
Septerna, Common Stock Summary
Septerna, Common competes with Vincerx Pharma, Viracta Therapeutics, Dogwood Therapeutics,, Viking Therapeutics, and Dyadic International. Septerna, Common is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Healthcare, Biotechnology |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| Location | California; U.S.A |
| Business Address | 250 East Grand |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | septerna.com |
| Phone | 650 338 3533 |
Septerna, Common Key Financial Ratios
| Total Asset | 130.87 M | ||||
| Retained Earnings | (46.58 M) |
Septerna, Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Septerna, Common's current stock value. Our valuation model uses many indicators to compare Septerna, Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Septerna, Common competition to find correlations between indicators driving Septerna, Common's intrinsic value. More Info.Septerna, Common Stock is currently regarded number one company in total debt category among its peers. It also is currently regarded as top stock in number of employees category among its peers . The ratio of Total Debt to Number Of Employees for Septerna, Common Stock is about 2,488,838 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Septerna, Common's earnings, one of the primary drivers of an investment's value.Septerna, Common Stock Systematic Risk
Septerna, Common's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Septerna, Common volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Septerna, Common Stock correlated with the market. If Beta is less than 0 Septerna, Common generally moves in the opposite direction as compared to the market. If Septerna, Common Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Septerna, Common Stock is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Septerna, Common is generally in the same direction as the market. If Beta > 1 Septerna, Common moves generally in the same direction as, but more than the movement of the benchmark.
Septerna, Common December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Septerna, Common help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Septerna, Common Stock. We use our internally-developed statistical techniques to arrive at the intrinsic value of Septerna, Common Stock based on widely used predictive technical indicators. In general, we focus on analyzing Septerna, Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Septerna, Common's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.19 | |||
| Information Ratio | 0.2025 | |||
| Maximum Drawdown | 26.27 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 12.32 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Septerna, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Septerna, Common. If investors know Septerna, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Septerna, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Septerna, Common Stock is measured differently than its book value, which is the value of Septerna, that is recorded on the company's balance sheet. Investors also form their own opinion of Septerna, Common's value that differs from its market value or its book value, called intrinsic value, which is Septerna, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Septerna, Common's market value can be influenced by many factors that don't directly affect Septerna, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Septerna, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Septerna, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Septerna, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.